Abbott India Limited (NSE:ABBOTINDIA)
26,195
-485 (-1.82%)
Nov 11, 2026, 1:03 PM IST
Abbott India Revenue
Abbott India had revenue of 19.51B INR in the quarter ending September 30, 2026, with 11.03% growth. This brings the company's total for the last twelve months to 71.98B, up 7.21% year-over-year. In the fiscal year ending March 31, 2026, Abbott India had annual revenue of 69.29B with 8.11% growth.
Revenue (ttm)
71.98B
Revenue Growth
+7.21%
P/S Ratio
7.87
Revenue / Employee
19.57M
Employees
3,679
Market Cap
555.96B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 69.29B | 5.20B | 8.11% |
| Mar 31, 2025 | 64.09B | 5.60B | 9.58% |
| Mar 31, 2024 | 58.49B | 5.00B | 9.35% |
| Mar 31, 2023 | 53.49B | 4.35B | 8.86% |
| Mar 31, 2022 | 49.13B | 6.03B | 14.00% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Aurobindo Pharma | 369.13B |
| Cipla | 279.89B |
| Glenmark Pharmaceuticals | 158.38B |
| Mankind Pharma | 153.79B |
| Alkem Laboratories | 150.81B |
| Ipca Laboratories | 104.70B |
| Emcure Pharmaceuticals | 102.34B |
| Piramal Pharma | 97.79B |
Abbott India News
- 6 days ago - Abbott India Quarterly report: Q2 2027 - Filings
- 3 months ago - Abbott India Quarterly report: Q1 2027 - Filings
- 6 months ago - Abbott India Quarterly report: Q4 2026 - Filings
- 6 months ago - Abbott India Annual report: Q4 2026 - Filings
- 8 months ago - Pharma sector stocks today, March 12: Divi's Laboratories down 1.87%, Abbott India drops 1.51%, Aarti Drugs falls 1.36% - Business Upturn
- 9 months ago - Abbott India Quarterly report: Q3 2026 - Filings
- 1 year ago - Abbott India Quarterly report: Q2 2026 - Filings
- 1 year ago - Abbott India Quarterly report: Q1 2026 - Filings